Search results for bethlem

Planning meeting held for clinical trial of Omigapil for congenital muscular dystrophy

Santhera has held an expert meeting in the US to assist with planning of the clinical trial of Omigapil for congenital muscular dystrophy....

Developing molecular patches for the treatment of collagen VI-related conditions

Background Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy (BM) are known as collagen VI-related myopathies, as they are caused by mutations in genes that produce collagen VI protein....

Investigating melanocytes as a model for collagen VI-related myopathies

This project is supported by the Collagen VI Alliance, which is made up of Muscular Dystrophy UK, Cure CMD (USA), Muscular Dystrophy Ireland, AFM Telethon (France), Swiss Foundation for Research on Muscle Disease (FSRMM)....

Facilitating clinical trials for collagen VI-related conditions

This project is supported by the Collagen VI Alliance, which is made up of Muscular Dystrophy UK, Cure CMD (USA), Muscular Dystrophy Ireland, AFM Telethon (France), Swiss Foundation for Research on Muscle Disease (FSRMM)....

Would you like to be part of the 100K genome project?

The 100K genome project is a government-funded project to sequence the genomes of 100 thousand genomes of people in the UK....

National Conference 2011 – research workshop

One of the highlights of this years national Conference 2011 was the research workshops. The scientists who attended the conference talked about the projects they are working on and showed some interesting posters explaining their research....

Nine cutting-edge new research projects awarded funding

Each year the Muscular Dystrophy Campaign invests more than one million pounds into research....

Taking part

If you are considering taking part in a clinical trial, we recommend registering your interest with your neurologist and reminding him or her regularly. Sometimes it’s possible to directly contact the centre involved in the clinical study....

Santhera receives orphan drug status approval for congenital muscular dystrophy drug

Swiss pharmaceutical company Santhera announced on 15 August 2008 that it had received orphan drug status approval for Omigapil....

Skydive for a friend

Experience the freedom that only skydiving can bring. And feel the joy when you do it for a friend who needs you to help beat muscular dystrophy. Read here about two big groups who are doing just that....

News

Near you

Find support and services in your area:

Keep in touch